A New Anti-VEGF Inhibitor, Aflibercept: Treatment Outcomes Of Neovascular Macular Degeneration Refractory To Other Anti-VEGF Agents
Purpose: To evaluate the treatment outcomes of aflibercept in patients with exudative age-related macular degeneration (AMD) resistant to other anti-vascular endothelial growth factor (VEGF) medications (bevacizumab, ranibizumab, and combination with or without dexamethasone and laser photocoagulati...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2014-04-01
|
| coleção: | Delhi Journal of Ophthalmology |
| Assuntos: | |
| Acesso em linha: | https://journals.lww.com/10.7869/djo.51 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|